Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kalyn Hoffman"'
Autor:
Jihad Aljabban, Saad Syed, Sharjeel Syed, Michael Rohr, Noah Weisleder, Kevin E. McElhanon, Laith Hasan, Laraib Safeer, Kalyn Hoffman, Nabeal Aljabban, Mohamed Mukhtar, Nikhil Adapa, Zahir Allarakhia, Maryam Panahiazar, Isaac Neuhaus, Susan Kim, Dexter Hadley, Wael Jarjour
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04866- (2020)
Aims: Dermatomyositis (DM) is a progressive, idiopathic inflammatory myopathy with poorly understood pathogenesis. A hallmark of DM is an increased risk for developing breast, ovarian, and lung cancer. Since autoantibodies against anti-TIF-1-γ, a me
Externí odkaz:
https://doaj.org/article/69b214ceceef4e5489ce1d16e32be58e
Autor:
Benjamin H. Kaffenberger, Catherine Chung, John Trinidad, Shawn G. Kwatra, Samir Parikh, Kalyn Hoffman
Publikováno v:
Journal of the American Academy of Dermatology. 83:1511-1513
Autor:
Catherine Chung, Daniel G. Stover, Jeffrey VanDeusen, Brittany O. Dulmage, Robert Wesolowski, Morgan A. Amigo, Benjamin H. Kaffenberger, Gabriel Tinoco Suarez, Maryam B. Lustberg, Mathew Cherian, Kalyn Hoffman
Publikováno v:
Journal of the American Academy of Dermatology. 86(6)
Autor:
Kalyn Hoffman, Sabrina Shearer, Benjamin H. Kaffenberger, Catherine Chung, Jessica A. Kaffenberger
Publikováno v:
International Journal of Dermatology. 59
Publikováno v:
Dermatology online journal. 26(1)
The combination of dabrafenib and trametinib is an important immunotherapy option for patients with BRAF V600 mutation-positive melanoma. This regimen has been reported to cause cutaneous eruptions. However, hair dysmorphology is not a reported side
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB76
Autor:
Laraib Safeer, Sharjeel Syed, Dexter Hadley, Maryam Panahiazar, Nikhil Adapa, Mohamed Mukhtar, Kevin E. McElhanon, Zahir Allarakhia, Isaac M. Neuhaus, Michael Rohr, Wael N. Jarjour, Noah Weisleder, Nabeal Aljabban, Jihad Aljabban, Kalyn Hoffman, Laith Hasan, Saad Syed, Susan Kim
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04866-(2020)
Aims Dermatomyositis (DM) is a progressive, idiopathic inflammatory myopathy with poorly understood pathogenesis. A hallmark of DM is an increased risk for developing breast, ovarian, and lung cancer. Since autoantibodies against anti-TIF-1-γ, a mem
Autor:
Zahir Allarakhia, Dexter Hadley, Mohamed Mukhtar, Sharjeel Syed, Habeeb Sura, Maryam Panahiazar, Mohammed Mohammed, Jihad Aljabban, Kalyn Hoffman, Saad Syed, Nabeal Aljabban
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB202